Clinical Trials
14 trialsNCT05643963 2025-12-11
The COOKER-BLADDER Trial
Hospital Centre Biel/Bienne
Phase NA Completed
NCT03081858 2025-06-27
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
Phase 1/2 Completed
NCT06395701 2024-09-19
Trimodality Treatment in Bladder Cancer
Consorci Sanitari de Terrassa
Completed
NCT04200963 2024-03-15
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Ikena Oncology
Phase 1 Completed
NCT00210249 2022-02-04
PHRC2003
Institut Bergonié
Completed
NCT04914442 2021-06-04
Eosinophilic Cystitis Mimicking Urothelial Neoplasia
Al-Azhar University
Completed
NCT03257293 2021-04-27
A Trial of a Modified Cystoscopy Method to Reduce Pain Perception
Western University, Canada
Phase NA Completed
NCT03591367 2019-11-04
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
Mansoura University
Phase NA Completed
NCT02300610 2019-08-01
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01803295 2017-06-16
OPTIMA
UroGen Pharma Ltd.
Phase NA Completed
NCT02307487 2017-06-16
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients
UroGen Pharma Ltd.
Phase 2 Completed
NCT02891460 2016-09-08
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients
UroGen Pharma Ltd.
Phase NA Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00615043 2010-12-22
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure
Tengion
Completed